Biopaws IVS: Financial statements 2018
CVR: 38407821
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Biopaws IVS (CVR 38407821) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 542,063 and a net result of DKK -25,501 compared with DKK 29,543 the year before. That is an increase of 30.6% compared with the year before. The profit margin was -4.7%. Equity in the 2018 report amounted to DKK 9,041. The solvency ratio was 44.9%.
- Revenue
- DKK 542,063
- Gross Profit
- DKK 259,225
- Profit/Loss
- DKK -25,501
- Equity
- DKK 9,041
- Total Assets
- DKK 20,146
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 542 t. | 259 t. | -26 t. | 9 t. | - |
| 2017 | 415 t. | 183 t. | 30 t. | 35 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of October 6, 2018, Dan Elkjær is registered as director of Biopaws IVS.
As of October 6, 2018, Susie Elkjær has stepped down as director of Biopaws IVS.
Biopaws IVS has published its interim report for the period February 10, 2017 – December 31, 2017.
About Biopaws IVS
Biopaws IVS was a Danish company of the type Iværksætterselskab based in Middelfart, founded in 2017. The company has been dissolved on 22 May 2019. The company was registered under the industry Ikke-specialiseret engroshandel. The company has 0 employees (2018). In 2018, the company reported revenue of DKK 542,063 and a net result of DKK -25,501 compared with DKK 29,543 the year before. Equity in the 2018 report amounted to DKK 9,041.